Advanced Research Projects Agency for Health

Last updated
Advanced Research Projects Agency for Health (ARPA-H)
Agency overview
FormedMarch 15, 2022;18 months ago (2022-03-15)
Jurisdiction Federal Government of the United States
Agency executives
Parent department Department of Health and Human Services
Parent agency National Institutes of Health
Website arpa-h.gov

The Advanced Research Projects Agency for Health (ARPA-H) is an independent entity within the National Institutes of Health. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity." [2]

Contents

ARPA-H was approved by Congress with the passing of H.R. 2471, the Consolidated Appropriations Act, 2022 and was signed into Public Law 117-103 by U.S. president Joe Biden on March 15, 2022. [3] 15 days later Health and Human Services Secretary Xavier Becerra announced that the agency will have access to the resources of the National Institutes of Health, but will answer to the U.S. Secretary of Health and Human Services. [4] The agency initially has a $1 billion budget to be used before fiscal year 2025 (October 2024) and the Biden administration has requested much more funding from Congress. On September 13, 2022, Biden announced his intent to appoint Renee Wegrzyn, formerly of the DARPA biotech office, as the agency's inaugural director, but it is still unknown where its headquarters will be located. [5]

In December 2022, the Consolidated Appropriations Act, 2023 (Pub.L. 117-328) provided $1.5 billion for ARPA-H for fiscal year 2023. The Biden administration is requesting $2.5 billion for FY2024. In March 2023, ARPA-H announced one of its three headquarters locations would be in the Washington metropolitan area. [6] [7] In September 2023, ARPA-H announced that a second hub would be located in Cambridge, Massachusetts following a bid led by U.S. Representative Richard Neal from Massachusetts's 1st congressional district and University of Massachusetts System President Marty Meehan to have the agency locate a hub in the Greater Boston area. [8] [9] The third patient engagement-focused hub was established in Dallas, Texas. [10]

History

The Defense Advanced Research Projects Agency (DARPA, formerly ARPA) has been the military's in-house innovator since 1958, a year after the USSR launched Sputnik. DARPA is widely known for creating ARPAnet, the predecessor of the internet, and has been instrumental in advancing hardened electronics, brain-computer interface technology, drones, and stealth technology. Inspired by the success of DARPA, in 2002 the Homeland Security Advanced Research Projects Agency (HSARPA) was created and in 2006 the Intelligence Advanced Research Projects Activity (IARPA) was created. This was followed by the Advanced Research Projects Agency–Energy (ARPA-E) in 2009 and the Advanced Research Projects Agency–Infrastructure (ARPA-I) in 2022. DARPA also inspired the Advanced Research and Invention Agency in the UK and in 2021 the Biden administration proposed ARPA-C for climate research. [11]

The Suzanne Wright Foundation proposed "HARPA" in 2017 to focus on pancreatic cancer and other challenging diseases. [12] IA white paper was published by former Obama White House staffers, Michael Stebbins and Geoffrey Ling through the Day One Project that proposed the creation of a new federal agency modeled on DARPA, but focused on health. That proposal was adopted by President Biden's campaign and was the model used for establishing ARPA-H. [13] In June 2021 noted biologists Francis S. Collins (then head of the NIH), Tara Schwetz, Lawrence Tabak, and Eric Lander penned an article in Science supporting the idea. [14] Dr. Collins became an important champion of the idea on Capitol Hill and the legislation garnered numerous sponsors in the 117th Congress.

In September 2022, Renee Wegrzyn was appointed as the agency's inaugural director. [15] [16] [17]

Research

A White House white paper identifies a number of potential directions for technological development that could occur under the direction of ARPA-H, including cancer vaccines, pandemic preparedness, and prevention technologies, less intrusive wearable blood glucose monitors, and patient-specific T-cell therapies. [18] Additionally, the proposal suggests that ARPA-H focus on platforms to reduce health disparities in maternal morbidity and mortality and improve how medications provided are taken.

Related Research Articles

<span class="mw-page-title-main">DARPA</span> Agency of the U.S. Department of Defense responsible for the development of new technologies

The Defense Advanced Research Projects Agency (DARPA) is a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for use by the military.

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

<span class="mw-page-title-main">Bob Wright</span> American businessman

Robert Charles Wright is an American lawyer, businessman, lobbyist, and author. He is a former NBC executive, having served as president and CEO from 1986 to 2001, and chairman and CEO from 2001 until he retired in 2007. He has been credited with overseeing the broadcast network's expansion into a media conglomerate and leading the company to record earnings in the 1990s. Prior to NBC, he held several posts at General Electric in the 1960s, 70s and 80s. He served as President and CEO of GE Capital, GE Financial Services 1983 to 1986 and served as GE's vice chairman until he retired from that role in 2008.

Homeland Security Advanced Research Projects Agency (HSARPA) is a part of the Science and Technology Directorate at the United States Department of Homeland Security. Much like DARPA in the Department of Defense, HSARPA is tasked with advanced projects to advance the technology needed to protect the US. Some of the chief beneficiaries of HSARPA are the Customs and Border Protection, and the Office of Intelligence and Analysis.

<span class="mw-page-title-main">Michael Stebbins</span> American geneticist

Michael Stebbins is an American geneticist and former Vice President of Science and Technology at the Laura and John Arnold Foundation. He previously served as Assistant Director for Biotechnology, at the White House Office of Science and Technology Policy.

<span class="mw-page-title-main">National Science and Technology Council</span> The NSTC establishes national goals for science and technology.

The National Science and Technology Council (NSTC) is a council in the Executive Branch of the United States. It is designed to coordinate science and technology policy across the branches of federal government.

ARPA-E, or Advanced Research Projects Agency–Energy is a United States government agency tasked with promoting and funding research and development of advanced energy technologies. It is modeled after the Defense Advanced Research Projects Agency (DARPA).

<span class="mw-page-title-main">Science policy of the United States</span> Government support and limits of scientific research

The science policy of the United States is the responsibility of many organizations throughout the federal government. Much of the large-scale policy is made through the legislative budget process of enacting the yearly federal budget, although there are other legislative issues that directly involve science, such as energy policy, climate change, and stem cell research. Further decisions are made by the various federal agencies which spend the funds allocated by Congress, either on in-house research or by granting funds to outside organizations and researchers.

The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.

<span class="mw-page-title-main">Geoffrey Ling</span>

Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. He was considered to be the "US Army's premier subject matter expert on traumatic brain injury (TBI)", and was for years the only neuro-intensive care specialist in the US military.

<span class="mw-page-title-main">Biotechnology industry in Boston</span>

Greater Boston, primarily Boston and Cambridge, is home to more than 1,000 biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies. The many universities in the area give the region a large network of scientists.

<span class="mw-page-title-main">Infrastructure Investment and Jobs Act</span> Legislation of the 117th United States Congress

The Infrastructure Investment and Jobs Act (IIJA), most commonly known as the Bipartisan Infrastructure Bill and originally in the House as the INVEST in America Act, is a United States federal statute enacted by the 117th United States Congress and signed into law by President Joe Biden on November 15, 2021.

<span class="mw-page-title-main">Lawrence A. Tabak</span> American dentist and scientist (born 1951)

Lawrence A. Tabak is an American dentist and biomedical scientist serving as the acting director of the National Institutes of Health. He is the principal deputy director of the National Institutes of Health. Tabak was director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.

<span class="mw-page-title-main">Tara A. Schwetz</span> American biophysicist and government official

Tara A. Schwetz is an American biophysicist and government administrator who is currently serving as the Acting Principal Deputy Director of the National Institutes of Health (NIH).

<span class="mw-page-title-main">Consolidated Appropriations Act, 2022</span>

Consolidated Appropriations Act, 2022 is a $1.5 trillion omnibus spending bill. The bill was passed by Congress on March 14, 2022. The bill was signed into law by President Joe Biden on March 15, 2022.

<span class="mw-page-title-main">Renee Wegrzyn</span> American applied biologist (born 1976)

Renee Diane Wegrzyn is an American applied biologist who has served as the inaugural director of the Advanced Research Projects Agency for Health since October 2022.

<span class="mw-page-title-main">Adam H. Russell</span> American anthropologist

Adam H. Russell is an American anthropologist who served as the acting deputy director of the Advanced Research Projects Agency for Health in 2022. He is the chief scientist of the Applied Research Laboratory for Intelligence and Security at the University of Maryland.

<span class="mw-page-title-main">Consolidated Appropriations Act, 2023</span> US omnibus spending bill

The Consolidated Appropriations Act, 2023 is a $1.7 trillion omnibus spending bill funding the U.S. federal government for the 2023 fiscal year. It includes funding for a range of domestic and foreign policy priorities, including support for Ukraine, defense spending, and aid for regions affected by natural disasters. It also includes provisions related to advanced transportation research, health care, electoral reform, and restrictions on the use of the social media app TikTok.

References

  1. ↑ "Russell Named Acting Deputy Director for New Advanced Research Entity". NIH Record . 2022-06-10. Retrieved 2022-08-28.
  2. ↑ "ARPA-H Mission". National Institutes of Health (NIH). 29 June 2021. Retrieved 27 April 2022.
  3. ↑ Jeffries, Hakeem S. (15 March 2022). "H.R.2471 - 117th Congress (2021-2022): Consolidated Appropriations Act, 2022". www.congress.gov. Retrieved 27 April 2022. Division H, Title II. Page 136 STAT. 465 contains relevant passage.
  4. ↑ Mesa, Natalie (1 April 2022). "ARPA-H to Be Within NIH but Independently Managed by HHS". The Scientist Magazine. Retrieved 27 April 2022.
  5. ↑ Kozlov, Max (13 September 2022). "Billion-dollar US health agency gets new chief — but its direction remains in limbo". Nature . Retrieved 14 September 2022.
  6. ↑ Kavya Sekar; Marcy E. Gallo (May 23, 2023). Advanced Research Projects Agency for Health (ARPA-H): Overview and Selected Issues (Report 47568) (PDF) (Report). Congressional Research Service. Retrieved July 1, 2023.
  7. ↑ Pub. L. Tooltip Public Law (United States)  117–328 (text) (PDF), Division FF, Title II (page 420 of engrossed bill)
  8. ↑ Weisman, Robert; Chesto, Jon (September 26, 2023). "Cambridge picked as a national hub for new federal health research agency". The Boston Globe. Retrieved September 26, 2023.
  9. ↑ Chesto, Jon (May 16, 2022). "The feds are choosing a headquarters for a federal health research center. Why not pick Boston?". The Boston Globe. Retrieved May 20, 2022.
  10. ↑ Pandey, Maia (2023-09-26). "Dallas selected as one of three national hubs for new medical innovation federal agency". The Texas Tribune. Retrieved 2023-10-13.
  11. ↑ Tollefson, Jeff (22 July 2021). "The rise of 'ARPA-everything' and what it means for science". Nature. 595 (7868): 483–484. Bibcode:2021Natur.595..483T. doi:10.1038/d41586-021-01878-z. PMID   34244687. S2CID   235787224 . Retrieved 27 April 2022.
  12. ↑ "HARPA: Health Advanced Research Projects Agency". The Suzanne Wright Foundation. Retrieved 27 April 2022.
  13. ↑ Stebbins, Michael; Ling, Geoffrey (19 April 2020). "Creating the Health Advanced Research Projects Agency (HARPA)". Federation of American Scientists. Retrieved 27 April 2022.
  14. ↑ Collins, Francis S.; Schwetz, Tara A.; Tabak, Lawrence A.; Lander, Eric S. (9 July 2021). "ARPA-H: Accelerating biomedical breakthroughs". Science. 373 (6551): 165–167. Bibcode:2021Sci...373..165C. doi:10.1126/science.abj8547. PMID   34244402. S2CID   235769725.
  15. ↑ "President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H)". The White House. 2022-09-12. Retrieved 2022-09-12.
  16. ↑ "DARPA Forward | Dr. Renee Wegrzyn". forward.darpa.mil. Retrieved 2022-09-12.
  17. ↑ "Biden's new biomedical innovation agency gets its first director". www.science.org. 2022-09-12. doi:10.1126/science.ade8505 . Retrieved 2022-09-18.
  18. ↑ "ARPA-H Frequently Asked Questions" (PDF). The White House. Retrieved 27 April 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.